Top Markets
#1 Black Phoenix Black Phoenix +366.91%
#2 Glidr Glidr +84.34%
#3 Gold Park Gold Park +55.04%
#4 Akedo Akedo +54.95%
#5 Acurast Acurast +36.49%
#6 BasedHype BasedHype +30.05%
#7 Avantis Avantis +25.87%
#8 Cryptopia Cryptopia +22.42%
#9 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +16.61%
#10 Quantum Resistant Ledger Quantum Resistant Ledger +16.15%
Coin of the day
Black Phoenix Black Phoenix
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Destiny Pharma plc Destiny Pharma plc

Destiny Pharma plc

DEST
Rang in Aktien #41144
Destiny Pharma plc is a biotechnology company based in Brighton, UK, founded in... Destiny Pharma plc is a biotechnology company based in Brighton, UK, founded in 1996, specializing in the identification, progression, and market introduction of pharmaceutical solutions for infectious diseases. The company's clinical pipeline includes NTCD-M3, currently in Phase III trials to prevent recurring Clostridioides difficile infections. Its XF-73 program features XF-73 Nasal, undergoing Phase II development for the prevention of post-surgical staphylococcal infections, and XF-73 Dermal, which is in Phase I for treating bacterial skin infections resistant to antibiotics. Additionally, Destiny Pharma's preclinical efforts involve SPOR-COV, a biotherapeutic product aimed at preventing COVID-19 and other viral respiratory diseases, and XF Drugs Biofilm, targeting antibiotic-resistant biofilm and bacterial aggregate infections. The company is also investigating further applications of its XF drugs for respiratory, oral mucosa, and ocular infections. Destiny Pharma maintains strategic alliances with various organizations, including China Medical System Holdings Limited, SporeGen Limited, the University of Southampton, Aston University, the University of Sheffield, Cardiff University, and Tianjin Medical University.
Aktienkurs
$0.04082105
Zuletzt synchronisiert: 2024-08-12
Marktkapitalisierung
$39.09K
Veränderung (1 Tag)
-19.83%
Veränderung (1 Jahr)
0.00%
Land
GB
Handel Destiny Pharma plc (DEST)

Kategorie

Healthcare
Operative Marge für Destiny Pharma plc (DEST)
Operative Marge zum August 2026 TTM: -790.08%
Laut den neuesten Finanzberichten und dem Aktienkurs von Destiny Pharma plc beträgt die aktuelle operative Marge (TTM) -790.08%. Am Ende des Jahres 2022 lag die operative Marge bei -5,104.35%.
Historie der operativen Marge von Destiny Pharma plc von 2013 bis 2026
Operative Marge zum Jahresende
Jahr Operative Marge ändert
2026 (TTM) -790.08% 0.00%
2023 -790.08% -84.52%
2022 -5,104.35% 7.13%
2021 -4,764.75% -90.95%
2020 -52,638.31% 2,654.95%
2019 -1,910.68% 0.00%
2018 0.00% 0.00%
2017 0.00% 0.00%
2016 0.00% 0.00%
2015 0.00% 0.00%
2014 0.00% 0.00%
2013 0.00% 0.00%
Operative Marge vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Operative Marge Differenz der operativen Marge Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
38.97% -100.05%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
28.81% -100.04%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00% -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
0.00% -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
31.23% -100.04%
BE
Was ist die operative Marge eines Unternehmens?
Die operative Marge ist ein wichtiger Indikator zur Bewertung der Rentabilität eines Unternehmens. Höhere operative Margen sind in der Regel besser, da sie zeigen, dass ein Unternehmen seine Produkte oder Dienstleistungen mit deutlichem Gewinn über den Produktionskosten verkauft. Die operative Marge wird berechnet, indem der Gewinn des Unternehmens durch seinen Umsatz geteilt wird.